Physician

Eniko Nagy-Wilde, MD

According to 2025 Medicare claims, Eniko Nagy-Wilde, MD (NPI: 1790071736) practices epileptologists in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is SUTTER VALLEY MEDICAL FOUNDATION (NPI: 1952327256; TIN: 941156581) and primary practice location at 95816-5616. Nagy-Wilde is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Nagy-Wilde's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 181 traditional Medicare patients, billed 1,650 HCPCS/CPT codes, and received $107,675 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 889 prescription claims across 117 beneficiaries totaling $464,689 in drug costs, led by Xcopri (Cenobamate). Open Payments data shows 31 records totaling $1,759. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $18,343 and ending at $107,675. Concurrently, Part D prescription costs have risen steadily, from $3,478 to $464,689. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	76	144	$18,343
2016	209	1,382	$78,454
2017	225	1,665	$92,658
2018	259	1,571	$115,392
2019	295	1,638	$134,448
2020	225	1,193	$72,624
2021	211	1,560	$82,937
2022	202	1,399	$59,179
2023	217	1,531	$90,733
2024	181	1,650	$107,675

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	18	$3,478
2016	60	357	$135,782
2017	86	555	$262,584
2018	75	710	$260,188
2019	93	800	$284,946
2020	105	866	$304,462
2021	108	1,025	$429,285
2022	106	904	$300,683
2023	100	794	$385,244
2024	117	889	$464,689

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95720	Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional	31	88	$165
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	83	150	$124
95816	Measurement of brain wave activity (eeg), awake and drowsy	37	38	$46
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	38	124	$26
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	56	61	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xcopri	Cenobamate	111	3,828	$159,098
Briviact	Brivaracetam	78	3,030	$142,218
Rufinamide	Rufinamide	13	396	$49,374
Levetiracetam Er	Levetiracetam	182	11,501	$26,810
Lamotrigine Er	Lamotrigine	53	3,886	$17,113

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$1,759	NEUROPACE, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eniko Nagy-Wilde, MD?

Tedicare shows public-source Medicare data for Eniko Nagy-Wilde, MD (NPI 1790071736), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eniko Nagy-Wilde, MD have ACO affiliation data?

Eniko Nagy-Wilde, MD is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Eniko Nagy-Wilde, MD?

Eniko Nagy-Wilde, MD is linked to SUTTER VALLEY MEDICAL FOUNDATION (billing NPI 1952327256) in the available physician profile data.

Does Eniko Nagy-Wilde, MD have Open Payments data?

Eniko Nagy-Wilde, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.